Role of Lymphoid/Mucosa-Associated Lymphoid Tissue Markers in Toxicological Immunohistochemistry



Fig. 9.1
Kierszenbaum AL. Histology and cell biology; an introduction to pathology. Immune-lymphatic system. p. 307, Mosby Elsevier, 2007. Reproduced with permission from Mosby Elsevier publication. Copyright © 2012, 2007, 2002 by Saunders, an imprint of Elsevier, Inc



Lymph nodes filter interstitial fluid which is drained by the afferent lymphatic vessels into the subcapsular sinuses of the regional lymph nodes. Lymph filtration helps in removal of foreign substances including infectious agents (bacteria, viruses, and parasites) and facilitates surveillance of incoming antigens and their interaction with B and T lymphocytes. Lymph nodes also play a critical role in the humoral and cell-mediated immune response by producing plasma cells which produce antibodies and T cells which contribute to both humoral and cell-mediated immune response.

The cortex contains lymphoid follicles which are morphologically and physiologically similar to that of splenic or MALT lymphoid follicles. There are two types of lymphoid follicles —primary and secondary. Mature naive B lymphocytes expressing specific receptor for specific antigens exit primary lymphoid organs and circulate the blood and lymphatics and home to secondary lymphoid organs [1]. On their arrival in secondary lymphoid organs, B lymphocytes exit through high endothelial venules (HEV) and home to the primary follicles. Those B lymphocytes that recognize the antigen undergo clonal expansion to form secondary lymphoid follicles characterized histologically by prominent germinal centers. Plasma cell precursors formed in germinal centers migrate to the medullary cords and produce monoclonal antibodies against specific antigen (Fig. 9.1) [1]. Sinuses contain veins and arteries and may be surrounded by macrophages. The gaps in the lining of medullary sinuses permit passage of cell from the efferent lymph directly to the medullary areas.


Hyperplastic Lesions


Hyperplasia in a lymph node can involve cortex (B cells), paracortex (T cells), medullary chords (plasma cells), and macrophages. Hyperplastic lesions of B cells are characterized by formation of lymphoid follicles with a prominent germinal center surrounded by mantle and marginal zones. The time to develop follicles in humans is closer to 2 weeks following antigenic exposure, whereas in dogs it is 10 days. Germinal centers are present predominantly in the cortex but may populate the paracortex with sustained antigenic stimulation. Germinal centers have a consistent architecture with the interior cells having a superficial or light pole and a deep or dark pole. Recognition of this polarity is important observation in distinguishing lymphoid hyperplasia from follicular lymphoma [2]. The cells within the superficial pole are small lymphocytes with a moderate amount of light-stained cytoplasm giving it a less dense appearance, whereas the cells of the deep pole are large lymphocytes with proportionally less cytoplasm that is deeply amphophilic, resulting in darker and compact appearance. Many tingible body macrophages are also scattered within the germinal centers and phagocytize lymphocytes whose antibody exhibits too high or too low avidity. Generally, well-developed germinal centers are not present at birth unless there has been intrauterine infection. The mantle cell zone is composed of relatively homogenous population of small lymphocytes that have round compact nuclei that lack nucleoli and have very little cytoplasm and give rise to pregerminal center B cells [2]. Marginal zone cells are not generally prominent in normal nodes but may become prominent in case of immune response [2]. The marginal zone cells have relatively abundant cytoplasm and round and larger nuclei with fine dispersed chromatin and a single nucleolus. These cells are believed to be memory cells [2]. Medullary cords are populated by plasma cells and macrophages. In the case of increased demand for erythropoiesis, cords can be populated by erythroid progenitors (extramedullary hematopoiesis). The immunohistochemical markers and their sources for macrophages and T and B cells are listed in Tables 9.1 and 9.2.


Table 9.1
Immunohistochemical markers of the immune system on paraffin sections in mouse













































































































Antibody

Major cells expressing antigen

Source

Product number

Bcl-2

Germinal center B cells

Santa Cruz Biotechnology

Sc-7382

Bcl-6

Germinal center B cells

Santa Cruz Biotechnology

Sc-858

Caspase-3 cleaved

Apoptotic cells

Cell Signaling Technology

2H12

CD3

T lymphocytes

Dako

A0452

CD19

B cells

Cell Signaling Technology

3574

CD21

B cells, follicular dendritic cells

Santa Cruz Biotechnology

Sc-7028FITC

CD30

Activated T and B cells

BD Biosciences

553824

CD43

T and B cells, myeloid cells

BD Biosciences

552366

CD45R/B220

B cells

BD Biosciences

553850

CD138 (Syndecan-1)

B cells, plasma cells

BD Biosciences

553714

F4/80

Histiocytes

Serotec

MCA497BB

IRF4

B cells, plasma cells

Santa Cruz Biotechnology

Sc-6059

Mac-2

Histiocytes

Cedarlane Laboratories

CL8942AP

Myeloperoxidase

Myeloid cells

Dako

A0398

Nitric oxide synthase (NOS2)

Myeloid cells

Santa Cruz Biotechnology

Sc-651

Pax5

B cells

Santa Cruz Biotechnology

Sc-1974

PNA-biotin

B cells, follicles, germinal centers

Vector Laboratories

B-1075

PU.1

B cells

Santa Cruz Biotechnology

Sc-5949

TdT

T cells

Lab Vision

Ab-2


Source: Ward J, et al. Immunohistochemical markers for the rodent immune system. Toxicol Pathol. 2006;34:616–30



Table 9.2
Immunohistochemical markers of the immune system on paraffin sections in rat





































































Antibody

Major cells expressing antigen

Source

Product number

CD3

T lymphocytes

Dako

A0452

CD4

T-helper cells

Serotec

MCA55G

CD5

Subset of T lymphocytes, NK cells

Serotec

MCA52G

CD8

Subset of T cells, NK cells

Serotec

MCA48G

CD25

Activated T cells

Serotec

MCA273R

CD43

All leukocytes excluding B cells

Serotec

MCA54G

CD45RC

B cells

Serotec

MCA53R

CD68

Myeloid cells

Serotec

MCA341R

IgM

B cells

Vector

BA-2020

MHC class II

B cells

Serotec

MCA46G

Immunoglobulin human kappa light chains

Immunoglobulin-producing B cells

Dako

A0191


Source: Ward J, et al. Immunohistochemical markers for the rodent immune system. Toxicol Pathol. 2006;34:616–30


Neoplastic Lesions


Tumors of lymphocyte origin ar e lymphosarcoma and leukemia. Lymphosarcoma is a solid tissue tumor arising in organs other than the bone marrow and are of B, T, and NK cell origin. However, in advanced stages, neoplastic cell can infiltrate the bone marrow. The term “lymphoma” implies benign tumor but almost all advanced lymphomas are malignant; therefore, “lymphosarcoma” is considered a better diagnosis. Histologically, lymphosarcoma can be diffuse or of nodular/follicular hierarchy origin, i.e., mantle zone, marginal zone, follicular, and T zone lymphomas. Leukemia is tumor of hematopoietic cells that originates in the bone marrow, e.g., RBC, neutrophils, eosinophils, megakaryocytes, lymphocytes, and monocytes. Neoplastic cells are present in the blood and/or bone marrow.

Lymphosarcoma in genetically intact mice often arises in the mesenteric lymph nodes, spleen, and intestinal Peyer’s patches. Involvement of lymph nodes can be primary or secondary [3]. In case of primary involvement, tumors originate in the lymph nodes, whereas they metastasize to regional lymph nodes in secondary involvement. The origin of metastases depends largely on the location of the primary neoplasm and subsequent spread to the regional lymph node, e.g., cervical and peritracheal lymph nodes are the most common metastatic sites for thyroid carcinomas. The mesenteric lymph nodes are common site of metastasis for small and large enteric carcinomas and enteric lymphoma. The mandibular lymph node is a common site for malignant Zymbal gland carcinoma metastasis.


Toxicologic Lesions


The evaluation of a p otential treatment-related effect and subsequent alteration in the gross and histologic morphology depend on the physical and chemical properties of toxicologic agent or test compound, site of administration, and duration of the study. For example, oral administration of a paraffin compound resulted in granulomatous inflammation in the mesenteric lymph nodes with accumulation of macrophages in sinuses [4]. However, common toxicologic lesions include lymphocyte degeneration, necrosis, apoptosis, depletion, atrophy, and lymphoid and macrophage hyperplasia. A survey of nonneoplastic lesions in the mandibular and mesenteric lymph nodes in control B6C3F1 mice revealed lymphoid hyperplasia, plasma cell hyperplasia, lymphoid depletion, inflammation, sinus histiocytosis, angiectasis, hemorrhage, pigmentation, and extramedullary hematopoiesis [3].

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 3, 2016 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Role of Lymphoid/Mucosa-Associated Lymphoid Tissue Markers in Toxicological Immunohistochemistry

Full access? Get Clinical Tree

Get Clinical Tree app for offline access